Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2272705rdf:typepubmed:Citationlld:pubmed
pubmed-article:2272705lifeskim:mentionsumls-concept:C0028066lld:lifeskim
pubmed-article:2272705lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:2272705lifeskim:mentionsumls-concept:C0280076lld:lifeskim
pubmed-article:2272705pubmed:issue11lld:pubmed
pubmed-article:2272705pubmed:dateCreated1991-2-26lld:pubmed
pubmed-article:2272705pubmed:abstractTextNifedipine (N) and dehydronifedipine (DHN) plasma levels were measured by gas chromatography in 37 patients before and 2 h after the intake of 20 mg N. They suffered from cardiovascular diseases and were treated with N in daily doses of 30 or 60 mg in combination with nitrates, beta-receptor blocking agents, digitoxin, saluretics and/or vasodilators for several weeks or months. Simultaneously, blood pressure and heart rate were measured. For comparison, six healthy volunteers between the ages of 25 and 46 years took 20 mg N on an empty stomach. Their mean plasma N level amounted to 47.7 (SD: 13.6) ng.ml-1, the DHN level reached a mean value of 46.7 (SD: 22.8) ng.ml-1 2 h after administration. The mean plasma N level of the patients rose from 14.1 to 34.1 ng.ml-1 and that of DHN, from 5.4 to 16.0 ng.ml-1. In 26 of 37 patients the heart rate increased without correlating with the altitude of the N level. The ratio DHN/N was 0.83 (SD 0.24) in the volunteers, while in the patients it amounted to 0.59 (SD 0.30). If the criterion DHN/N plasma level reached values greater than 1.0 the N degradation was enhanced (n = 4), and if it reached values less than 0.2, N degradation was depressed (n = 9). The results did not indicate inhibition of N degradation under long-term treatment with simultaneously administered cardioactive drugs.lld:pubmed
pubmed-article:2272705pubmed:languageenglld:pubmed
pubmed-article:2272705pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272705pubmed:citationSubsetIMlld:pubmed
pubmed-article:2272705pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272705pubmed:statusMEDLINElld:pubmed
pubmed-article:2272705pubmed:monthNovlld:pubmed
pubmed-article:2272705pubmed:issn0174-4879lld:pubmed
pubmed-article:2272705pubmed:authorpubmed-author:HausteinK OKOlld:pubmed
pubmed-article:2272705pubmed:authorpubmed-author:AssmannIIlld:pubmed
pubmed-article:2272705pubmed:authorpubmed-author:MalletEElld:pubmed
pubmed-article:2272705pubmed:issnTypePrintlld:pubmed
pubmed-article:2272705pubmed:volume28lld:pubmed
pubmed-article:2272705pubmed:ownerNLMlld:pubmed
pubmed-article:2272705pubmed:authorsCompleteYlld:pubmed
pubmed-article:2272705pubmed:pagination458-61lld:pubmed
pubmed-article:2272705pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:meshHeadingpubmed-meshheading:2272705-...lld:pubmed
pubmed-article:2272705pubmed:year1990lld:pubmed
pubmed-article:2272705pubmed:articleTitleInteraction between nifedipine and cardioactive drugs.lld:pubmed
pubmed-article:2272705pubmed:affiliationInstitute of Clinical Pharmacology, Medical Academy Erfurt, Germany.lld:pubmed
pubmed-article:2272705pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2272705pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2272705pubmed:publicationTypeComparative Studylld:pubmed